ABS course Map
-
Oncology update on adjuvant extended endocrine treatment and adjuvant bisphosphonates
Dr Catherine Harper-Wynne | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Bisphosphonates
-
desktop_windows
Bisphosphonates – for whom and for how long?
Prof John Benson | ABS Conference 2018
18.06.2018 | Added: 18.06.2018
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates
desktop_windowsWebcast desktop_windows -
desktop_windows
Bone Health and adjuvant bisphosphonates
Dr Catherine Harper-Wynne | ABS Conference 2017
15.05.2017 | Added: 15.05.2017
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates
desktop_windowsWebcast desktop_windows -
list
Clinical advice to Cancer Alliances for the provision of Breast Cancer Services
The 2017 publication from the Breast Cancer Clinical Expert Group is not a guidance document per se but instead a list of best practice recommendations to commissioners and acute trusts for a modern b...
Breast Cancer Clinical Expert Group, UK | United Kingdom
18.02.2017 | Added: 18.02.2017
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates Service Guidance Breast Cancer Services
listGuideline list -
desktop_windows
Bisphosphonates/ denosumab for the treatment of early breast cancer: Do they increase survival?
Dr Andreas Makris | ABS Conference 2016
16.05.2016 | Added: 16.05.2016
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates Early Breast Cancer
desktop_windowsWebcast desktop_windows -
list
Benefits of Adjuvant Bisphosphonates in Post menopausal women
The UK Breast Cancer Group have produced a very helpful 2 page summary of the benefits of bisphosphonates as adjuvant treatment in breast cancer patients.
UK National Breast Clinical Reference Group & UK Breast Cancer Group, UK | United Kingdom
18.02.2016 | Added: 18.02.2016
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates
listGuideline list -
desktop_windows
The role of bisphosphonates as anticancer agents
Prof Rob Coleman | ABS Conference 2014
19.05.2014 | Added: 19.05.2014
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates
desktop_windowsWebcast desktop_windows